India’s Cipla launches copy of GSK’s top asthma drug in Germany, Sweden – Reuters


Economic Times

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla targets US with asthma, HIV drugsMoneyweb.co.za

all 22 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.